Has Hosai Todd Hesham, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,348 in general payments to Hosai Todd Hesham, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hosai Todd Hesham, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hosai Todd Hesham, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hosai Todd Hesham, MD

Otolaryngology · Roanoke, VANPI 1225288608

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,224 of the $7,348 with a category attached, or 71.1%. 24 manufacturers reported payments, led by Stryker at 42.9% of the total. Reporting peaked in 2020 at $2,425 and has fallen 59.8% since, to $974 in 2025. Among otolaryngology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,348in general payments, 2019–2025

Across 143 payments — averaging $51.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$3K
Inspire Medical Systems, Inc.$1K
Aerin Medical Inc.$583
AstraZeneca$429
GSK$388
Regeneron Healthcare Solutions, Inc.$375
plus $1K from 18 others

What the payments were for

Travel & lodging$2,12429%
Food & beverage$5,22471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	21	$3,153
Inspire Medical Systems, Inc.	12	$1,062
Aerin Medical Inc.	10	$583
AstraZeneca	16	$429
GSK	13	$388
Regeneron Healthcare Solutions, Inc.	12	$375
Sanofi	13	$330
Optinose US, Inc.	10	$184
Kaleo, Inc.	8	$160
Intersect ENT, Inc.	2	$104
Boehringer Ingelheim	5	$103
Medtronic	2	$84
Genentech USA, Inc.	3	$70
Integra Lifesciences Corporation	3	$53
Hill Dermaceuticals, Inc.	1	$45
Acclarent, Inc	2	$38
Merck	2	$29
Hikma Pharmaceuticals USA	2	$29
Itamar Medical Inc	1	$28
Alk-abello, Inc	1	$24
Novartis	1	$21
ARS Pharmaceuticals Operations, Inc.	1	$21
Covis Pharma GmbH	1	$21
Johnson & Johnson	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENTELLUS - XPRESS ENT DILATION SYSTEM$2,259
Inspire$718
VIVAER STYLUS$197
XPRESS LOPROFILE$172
AUDION ET DILATION SYSTEM$170
XPRESS ENT DILATION SYSTEM$140
NUCALA$124
Inspire Upper Airway Stimulation System$118
DUPIXENT$109

How this compares

$7,348 in reported general payments places this provider in the 90th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia →

Medicare billing

Part B allowed, 2024

$151,256

Medicare patients

430

Services billed

1,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone	11	$2,518
Ipratropium Bromide	49	$1,801
Fluticasone Propionate	94	$1,768
Azelastine Hcl	31	$1,421
Ofloxacin	18	$984
Famotidine	53	$843
Acetic Acid	13	$231
Mupirocin	21	$197
Montelukast Sodium	11	$179
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$132
Prednisone	14	$13

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Roanoke

Paul LenkowskiRoanoke$282K
John SinacoriRoanoke$6K
Patrick CarpenterRoanoke$6K
Laurence OhalloranAnnandale$2.9M
Joseph HanNorfolk$1.8M
Ryan NordRichmond$454K
Nipun ChhabraLeesburg$178K
Kent LamNorfolk$127K
Spencer PayneCharlottesville$45K
Jose MattosCharlottesville$24K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →